University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

A recent study published in the journal of Eye journal revealed a significant reciprocal link between atrial fibrillation (AF) and age-related macular degeneration (AMD) in the elderly.

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...

Coave Therapeutics has announced its lead gene therapy program, CoTx-101, for the treatment of retinal vascular diseases, ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...